(transducing-like enhancer of split) (5)" should read as follows. "MORF4L1 has been reported to interact with retinoblastoma protein (Rb) and Pam14 (18, 19) , with histone acetyltransferase hMOF (human males absent on the first) (20), and with Sin3A and TLE (transducinglike enhancer of split) (5)."
PAGE 7093:
Left column, line 8: The following sentence should be deleted. "This domain contains the acetyltransferase activity that modifies lysine residues of histone substrates at a lower affinity and a leucine zipper domain that provides a platform to mediate interaction with many transcriptional regulators (23)."
Left column, second paragraph, line 1: "Homodimeric formation of MORF4L1 is important in regulating its acetyltransferase activity (22)" should read as follows. "Homodimeric formation of MORF4L1 might regulate its cellular function."
PAGE 7094:
Left column, fourth paragraph, line 1: "Gel filtration and size exclusion chromatographic studies reported that histone acetyltransferase MORF4L1 is located in two fractions: one is around 70 kDa and another approximately 700 kDa (20, 28)" should read as follows. "Gel filtration and size exclusion chromatographic studies reported that MORF4L1 is located in two fractions: one is around 70 kDa and another approximately 700 kDa (20, 28) ."
PAGE 7097:
Right column, third paragraph, line 10: "The Lys-148 acetylation/ deacetylation status may also provide a unique platform to regulate corepressor complex integrity, thus modulating the function of the acetyltransferase" should read as follows. "The Lys-148 acetylation/ deacetylation status may also provide a unique platform to regulate corepressor complex integrity and thus its activity."
Right column, third paragraph, line 13: "Further investigation of the modification of molecular acceptor sites between the CD and MRG domain of MORF4L1 are of interest, as is their physiologic role in governing MORF4L1 localization and acetyltransferase activity" should read as follows. "Further investigation of the modification of molecular acceptor sites between the CD and MRG domain of MORF4L1 are of interest, as is their physiologic role in governing MORF4L1 localization and activity."
